These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8785476)

  • 1. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
    Xing Z; Mahadeviah S; Whitton JL
    Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect.
    Gebhard JR; Perry CM; Mahadeviah S; Whitton JL
    Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):3-11. PubMed ID: 9055033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.
    Xing Z; Whitton JL
    J Virol; 1993 Apr; 67(4):1840-7. PubMed ID: 8445712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activity.
    Zhang Z; Burke JM
    J Virol; 2005 Mar; 79(6):3728-36. PubMed ID: 15731266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of viral multiplication in acute and chronic stages of infection by ribozymes targeted against the polymerase gene of mouse hepatitis virus.
    Maeda A; Mizutani T; Hayashi M; Ishida K; Watanabe T; Namioka S
    Adv Exp Med Biol; 1995; 380():399-404. PubMed ID: 8830515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of viral multiplication by hammerhead ribozymes targeted against the polymerase gene of mouse hepatitis virus.
    Maeda A; Mizutani T; Hayashi M; Watanabe T; Namioka S
    J Vet Med Sci; 1994 Oct; 56(5):939-45. PubMed ID: 7532438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozymes which cleave arenavirus RNAs: identification of susceptible target sites and inhibition by target site secondary structure.
    Xing Z; Whitton JL
    J Virol; 1992 Mar; 66(3):1361-9. PubMed ID: 1738195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
    Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
    Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
    Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
    Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
    Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozyme inhibition of alphavirus replication.
    Seyhan AA; Vitiello D; Shields MT; Burke JM
    J Biol Chem; 2002 Jul; 277(29):25957-62. PubMed ID: 12006558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition.
    Zhou C; Bahner I; Rossi JJ; Kohn DB
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.
    Grosfeld H; Hill MG; Collins PL
    J Virol; 1995 Sep; 69(9):5677-86. PubMed ID: 7637014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Moloney murine leukaemia virus by a retroviral vector, LNL6, carrying ribozymes targeted to the 5' non-coding sequence.
    Lowenstein P; Symonds G
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2587-90. PubMed ID: 9349479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific gene suppression by engineered ribozymes in monkey cells.
    Cameron FH; Jennings PA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9139-43. PubMed ID: 2556702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme mediated destruction of influenza A virus in vitro and in vivo.
    Tang XB; Hobom G; Luo D
    J Med Virol; 1994 Apr; 42(4):385-95. PubMed ID: 8046429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.
    Lee KJ; Novella IS; Teng MN; Oldstone MB; de La Torre JC
    J Virol; 2000 Apr; 74(8):3470-7. PubMed ID: 10729120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.